Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 384

1.

Hyperacute Antibody-mediated Rejection Associated With Red Blood Cell Antibodies.

Shaw J, Gibson IW, Wiebe C, Houston DS, Koulack J, Rush D, Nickerson P, Ho J.

Transplant Direct. 2019 Jul 25;5(8):e477. doi: 10.1097/TXD.0000000000000925. eCollection 2019 Aug. No abstract available.

2.

LATE GRAFT LOSS AFTER KIDNEY TRANSPLANTATION: IS "DEATH WITH FUNCTION" REALLY DEATH WITH A FUNCTIONING ALLOGRAFT?

Gaston RS, Fieberg A, Helgeson ES, Eversull J, Hunsicker L, Kasiske BL, Leduc R, Rush D, Matas AJ; DeKAF Investigators.

Transplantation. 2019 Sep 13. doi: 10.1097/TP.0000000000002961. [Epub ahead of print]

PMID:
31568212
3.

Early Antibody-Mediated Kidney Transplant Rejection Associated With Anti-Vimentin Antibodies: A Case Report.

Rampersad C, Shaw J, Gibson IW, Wiebe C, Rush DN, Nickerson PW, Ho J.

Am J Kidney Dis. 2019 Sep 9. pii: S0272-6386(19)30885-6. doi: 10.1053/j.ajkd.2019.06.010. [Epub ahead of print]

PMID:
31515140
4.

Activity-based Protein Profiling Approaches for Transplantation.

Navarrete M, Wilkins JA, Lao Y, Rush DN, Nickerson PW, Ho J.

Transplantation. 2019 Sep;103(9):1790-1798. doi: 10.1097/TP.0000000000002752.

PMID:
30985576
5.

Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients.

Ho J, Sharma A, Kroeker K, Carroll R, De Serres S, Gibson IW, Hirt-Minkowski P, Jevnikar A, Kim SJ, Knoll G, Rush DN, Wiebe C, Nickerson P.

BMJ Open. 2019 Apr 11;9(4):e024908. doi: 10.1136/bmjopen-2018-024908.

6.

Subclinical Inflammation in Renal Transplantation.

Rush DN, Gibson IW.

Transplantation. 2019 Jun;103(6):e139-e145. doi: 10.1097/TP.0000000000002682.

PMID:
30801537
7.

Non-invasive differentiation of non-rejection kidney injury from acute rejection in pediatric renal transplant recipients.

Archdekin B, Sharma A, Gibson IW, Rush D, Wishart DS, Blydt-Hansen TD.

Pediatr Transplant. 2019 May;23(3):e13364. doi: 10.1111/petr.13364. Epub 2019 Feb 4.

PMID:
30719822
8.

Mucinous adenocarcinoma of the endometrium with metastasis to the clitoral glans after pelvic exenteration for radiation resistant vaginal cuff recurrence.

Mogor O, Hargrave E, Rush D, Hatch K.

Gynecol Oncol Rep. 2018 Dec 21;27:46-49. doi: 10.1016/j.gore.2018.12.003. eCollection 2019 Feb.

9.

Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts.

Cockfield SM, Wilson S, Campbell PM, Cantarovich M, Gangji A, Houde I, Jevnikar AM, Keough-Ryan TM, Monroy-Cuadros FM, Nickerson PW, Pâquet MR, Ramesh Prasad GV, Senécal L, Shoker A, Wolff JL, Howell J, Schwartz JJ, Rush DN.

Am J Transplant. 2019 Jun;19(6):1730-1744. doi: 10.1111/ajt.15225. Epub 2019 Feb 1.

10.

Long-term follow-up of the DeKAF cross-sectional cohort study.

Matas AJ, Fieberg A, Mannon RB, Leduc R, Grande J, Kasiske BL, Cecka M, Gaston R, Hunsicker L, Connett J, Cosio F, Gourishankar S, Rush D.

Am J Transplant. 2019 May;19(5):1432-1443. doi: 10.1111/ajt.15204. Epub 2019 Jan 24.

PMID:
30506642
11.

HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity.

Wiebe C, Kosmoliaptsis V, Pochinco D, Gibson IW, Ho J, Birk PE, Goldberg A, Karpinski M, Shaw J, Rush DN, Nickerson PW.

Am J Transplant. 2019 Jun;19(6):1708-1719. doi: 10.1111/ajt.15177. Epub 2018 Dec 15.

12.

Phenotype of vigilin expressing breast cancer cells binding to the 69 nt 3'UTR element in CSF-1R mRNA.

Woo HH, Lee SC, Stoffer JB, Rush D, Chambers SK.

Transl Oncol. 2019 Jan;12(1):106-115. doi: 10.1016/j.tranon.2018.09.012. Epub 2018 Oct 3.

13.

Non-invasive staging of chronic kidney allograft damage using urine metabolomic profiling.

Landsberg A, Sharma A, Gibson IW, Rush D, Wishart DS, Blydt-Hansen TD.

Pediatr Transplant. 2018 Aug;22(5):e13226. doi: 10.1111/petr.13226. Epub 2018 May 31.

PMID:
29855144
14.

Evolution of renal function and urinary biomarker indicators of inflammation on serial kidney biopsies in pediatric kidney transplant recipients with and without rejection.

Mincham CM, Gibson IW, Sharma A, Wiebe C, Mandal R, Rush D, Nickerson P, Ho J, Wishart DS, Blydt-Hansen TD.

Pediatr Transplant. 2018 Aug;22(5):e13202. doi: 10.1111/petr.13202. Epub 2018 Apr 25.

PMID:
29696778
15.

Carpe diem-Time to transition from empiric to precision medicine in kidney transplantation.

Wiebe C, Ho J, Gibson IW, Rush DN, Nickerson PW.

Am J Transplant. 2018 Jul;18(7):1615-1625. doi: 10.1111/ajt.14746. Epub 2018 Apr 30.

16.

Pre-transplant AT1R antibodies correlate with early allograft rejection.

Gareau AJ, Wiebe C, Pochinco D, Gibson IW, Ho J, Rush DN, Nickerson PW.

Transpl Immunol. 2018 Feb;46:29-35. doi: 10.1016/j.trim.2017.12.001. Epub 2017 Dec 5.

PMID:
29217423
17.

Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17.

Faddoul G, Nadkarni GN, Bridges ND, Goebel J, Hricik DE, Formica R, Menon MC, Morrison Y, Murphy B, Newell K, Nickerson P, Poggio ED, Rush D, Heeger PS; CTOT-17 consortium.

Transplantation. 2018 Apr;102(4):673-680. doi: 10.1097/TP.0000000000002026.

18.

Safety of Rolled and Folded Cotton Blankets Warmed in 130°F and 200°F Cabinets.

Kelly PA, Morse EC, Swanfeldt JV, Adams AN, Crandall CG, Rush DA, Krogh ML, Cooper SK.

J Perianesth Nurs. 2017 Dec;32(6):600-608. doi: 10.1016/j.jopan.2016.03.013. Epub 2017 Jan 10.

PMID:
29157766
19.

Late graft failure after kidney transplantation as the consequence of late versus early events.

Gaston RS, Fieberg A, Hunsicker L, Kasiske BL, Leduc R, Cosio FG, Gourishankar S, Grande J, Mannon RB, Rush D, Cecka JM, Connett J, Matas AJ.

Am J Transplant. 2018 May;18(5):1158-1167. doi: 10.1111/ajt.14590. Epub 2017 Dec 5.

20.
21.

Methanotroph-derived bacteriohopanepolyol signatures as a function of temperature related growth, survival, cell death and preservation in the geological record.

Osborne KA, Gray ND, Sherry A, Leary P, Mejeha O, Bischoff J, Rush D, Sidgwick FR, Birgel D, Kalyuzhnaya MG, Talbot HM.

Environ Microbiol Rep. 2017 Oct;9(5):492-500. doi: 10.1111/1758-2229.12570. Epub 2017 Oct 2.

PMID:
28772060
22.

Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development.

Wiebe C, Rush DN, Nevins TE, Birk PE, Blydt-Hansen T, Gibson IW, Goldberg A, Ho J, Karpinski M, Pochinco D, Sharma A, Storsley L, Matas AJ, Nickerson PW.

J Am Soc Nephrol. 2017 Nov;28(11):3353-3362. doi: 10.1681/ASN.2017030287. Epub 2017 Jul 20.

23.

Subclinical Antibody-Mediated Rejection.

Arias M, Serón D, Herrero I, Rush DN, Wiebe C, Nickerson PW, Ussetti P, Rodrigo E, de Cos MA.

Transplantation. 2017 Jun;101(6S Suppl 1):S1-S18. doi: 10.1097/TP.0000000000001735. Review. No abstract available.

PMID:
28538291
24.

Axillary Artery Aneurysm Presenting as Acute Limb Ischemia.

Ramseyer MM, Rush DS.

Am Surg. 2016 Dec 1;82(12):e336-337. No abstract available.

PMID:
28234161
25.

Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile.

Duvall JR, Bedard L, Naylor-Olsen AM, Manson AL, Bittker JA, Sun W, Fitzgerald ME, He Z, Lee MD 4th, Marie JC, Muncipinto G, Rush D, Xu D, Xu H, Zhang M, Earl AM, Palmer MA, Foley MA, Vacca JP, Scherer CA.

ACS Infect Dis. 2017 May 12;3(5):349-359. doi: 10.1021/acsinfecdis.6b00206. Epub 2017 Mar 7.

26.

Percutaneous Treatment of Superficial Femoral Artery Stenosis Secondary to Radiation Arteritis.

Pham HD, Prather MG, Rush DS.

Am Surg. 2016 Nov 1;82(11):1098-1100.

PMID:
28206937
27.

Lipids as paleomarkers to constrain the marine nitrogen cycle.

Rush D, Sinninghe Damsté JS.

Environ Microbiol. 2017 Jun;19(6):2119-2132. doi: 10.1111/1462-2920.13682. Epub 2017 Feb 28. Review.

28.

Urinary Metabolomics for Noninvasive Detection of Antibody-Mediated Rejection in Children After Kidney Transplantation.

Blydt-Hansen TD, Sharma A, Gibson IW, Wishart DS, Mandal R, Ho J, Nickerson P, Rush D.

Transplantation. 2017 Oct;101(10):2553-2561. doi: 10.1097/TP.0000000000001662.

PMID:
28121909
29.

Costimulation Blockade Holds Emerging Hope for Patients in Large Markets Only.

Gill JS, Halloran P, Jevnikar T, Cole E, Rush D, Knoll G.

Am J Transplant. 2017 Apr;17(4):1147. doi: 10.1111/ajt.14193. Epub 2017 Jan 31. No abstract available.

30.

The Curious Case of the Uterine Cyst.

Carpenter AM, Rush DS, Moawad NS.

J Minim Invasive Gynecol. 2017 Sep - Oct;24(6):884-885. doi: 10.1016/j.jmig.2016.11.017. Epub 2016 Dec 19. No abstract available.

PMID:
28007590
31.

Influence of Chronic Heat Acclimatization on Occupational Thermal Strain in Tropical Field Conditions.

Brearley MB, Norton I, Rush D, Hutton M, Smith S, Ward L, Fuentes H.

J Occup Environ Med. 2016 Dec;58(12):1250-1256.

32.

The Bacteriohopanepolyol Inventory of Novel Aerobic Methane Oxidising Bacteria Reveals New Biomarker Signatures of Aerobic Methanotrophy in Marine Systems.

Rush D, Osborne KA, Birgel D, Kappler A, Hirayama H, Peckmann J, Poulton SW, Nickel JC, Mangelsdorf K, Kalyuzhnaya M, Sidgwick FR, Talbot HM.

PLoS One. 2016 Nov 8;11(11):e0165635. doi: 10.1371/journal.pone.0165635. eCollection 2016.

33.

Endometrial Thickness as Measured by Transvaginal Ultrasound and the Corresponding Histopathologic Diagnosis in Women With Postmenopausal Bleeding.

Patel V, Wilkinson EJ, Chamala S, Lu X, Castagno J, Rush D.

Int J Gynecol Pathol. 2017 Jul;36(4):348-355. doi: 10.1097/PGP.0000000000000344.

PMID:
27801761
34.

Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.

Hirt-Minkowski P, Rush DN, Gao A, Hopfer H, Wiebe C, Nickerson PW, Schaub S, Ho J.

Transplantation. 2016 Sep;100(9):1988-96. doi: 10.1097/TP.0000000000001304.

PMID:
27548845
35.

Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft Survival.

Wiebe C, Gareau AJ, Pochinco D, Gibson IW, Ho J, Birk PE, Blydt-Hansen T, Karpinski M, Goldberg A, Storsley L, Rush DN, Nickerson PW.

Am J Transplant. 2017 Mar;17(3):703-711. doi: 10.1111/ajt.14015. Epub 2016 Oct 3.

36.

Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10.

Ho J, Sharma A, Mandal R, Wishart DS, Wiebe C, Storsley L, Karpinski M, Gibson IW, Nickerson PW, Rush DN.

Transplant Direct. 2016 May 19;2(6):e78. doi: 10.1097/TXD.0000000000000589. eCollection 2016 Jun.

37.

Prediction of Long-term Renal Allograft Outcome By Early Urinary CXCL10 Chemokine Levels.

Hirt-Minkowski P, Ho J, Gao A, Amico P, Koller MT, Hopfer H, Rush DN, Nickerson PW, Schaub S.

Transplant Direct. 2015 Sep 24;1(8):e31. doi: 10.1097/TXD.0000000000000537. eCollection 2015 Sep.

38.

Analysis of non-derivatised bacteriohopanepolyols by ultrahigh-performance liquid chromatography/tandem mass spectrometry.

Talbot HM, Sidgwick FR, Bischoff J, Osborne KA, Rush D, Sherry A, Spencer-Jones CL.

Rapid Commun Mass Spectrom. 2016 Oct 15;30(19):2087-98. doi: 10.1002/rcm.7696.

PMID:
27472174
39.

Pilot assessment of a human extracellular matrix-based vascular graft in a rabbit model.

Amensag S, Goldberg L, O'Malley KA, Rush DS, Berceli SA, McFetridge PS.

J Vasc Surg. 2017 Mar;65(3):839-847.e1. doi: 10.1016/j.jvs.2016.02.046. Epub 2016 Apr 29.

40.

Elevated Urinary Matrix Metalloproteinase-7 Detects Underlying Renal Allograft Inflammation and Injury.

Ho J, Rush DN, Krokhin O, Antonovici M, Gao A, Bestland J, Wiebe C, Hiebert B, Rigatto C, Gibson IW, Wilkins JA, Nickerson PW.

Transplantation. 2016 Mar;100(3):648-54. doi: 10.1097/TP.0000000000000867.

PMID:
26906940
41.

Trabecular bone score in kidney transplant recipients.

Naylor KL, Lix LM, Hans D, Garg AX, Rush DN, Hodsman AB, Leslie WD.

Osteoporos Int. 2016 Mar;27(3):1115-1121. doi: 10.1007/s00198-015-3424-3. Epub 2015 Nov 25.

PMID:
26608055
42.

Reconsidering gender relative to risk of rupture in the contemporary management of abdominal aortic aneurysms.

Skibba AA, Evans JR, Hopkins SP, Yoon HR, Katras T, Kalbfleisch JH, Rush DS.

J Vasc Surg. 2015 Dec;62(6):1429-36. doi: 10.1016/j.jvs.2015.07.079. Epub 2015 Sep 26.

43.

The perils of immunosuppression minimization: lessons from protocol biopsies of renal allografts.

Rush DN, Gibson IW.

Curr Opin Nephrol Hypertens. 2015 Nov;24(6):582-6. doi: 10.1097/MNH.0000000000000170. Review.

PMID:
26371528
44.

Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study.

Hricik DE, Augustine J, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, Spain K, Iklé D, Bridges ND, Heeger PS; CTOT-01 consortium.

Am J Transplant. 2015 Dec;15(12):3166-73. doi: 10.1111/ajt.13401. Epub 2015 Jul 30.

45.

Donor-specific anti-HLA antibodies in pediatric renal transplant recipients with creeping creatinine: Prevalence, histological correlations, and impact on patient and graft survival.

Monteverde ML, Chaparro A, Goldberg J, Marcos CY, Padros K, Balbarrey Z, Briones L, Rush D.

Pediatr Transplant. 2015 Nov;19(7):684-90. doi: 10.1111/petr.12556. Epub 2015 Jul 24.

PMID:
26212912
46.

Management of late main-body aortic endograft component uncoupling and type IIIa endoleak encountered with the Endologix Powerlink and AFX platforms.

Skibba AA, Evans JR, Greenfield DT, Yoon HR, Katras T, Ouriel K, Rush DS.

J Vasc Surg. 2015 Oct;62(4):868-75. doi: 10.1016/j.jvs.2015.04.454. Epub 2015 Jul 2.

47.

Urinary biomarkers of renal transplant outcome.

Ho J, Rush DN, Nickerson PW.

Curr Opin Organ Transplant. 2015 Aug;20(4):476-81. doi: 10.1097/MOT.0000000000000208. Review.

PMID:
26107968
48.

Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody.

Wiebe C, Gibson IW, Blydt-Hansen TD, Pochinco D, Birk PE, Ho J, Karpinski M, Goldberg A, Storsley L, Rush DN, Nickerson PW.

Am J Transplant. 2015 Nov;15(11):2921-30. doi: 10.1111/ajt.13347. Epub 2015 Jun 10.

49.

Of rock docs, frequent fliers and marijuana.

Rush D.

Alaska Med. 2014 Sep;55:2. No abstract available.

PMID:
26043488
50.

Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.

Hricik DE, Formica RN, Nickerson P, Rush D, Fairchild RL, Poggio ED, Gibson IW, Wiebe C, Tinckam K, Bunnapradist S, Samaniego-Picota M, Brennan DC, Schröppel B, Gaber O, Armstrong B, Ikle D, Diop H, Bridges ND, Heeger PS; Clinical Trials in Organ Transplantation-09 Consortium.

J Am Soc Nephrol. 2015 Dec;26(12):3114-22. doi: 10.1681/ASN.2014121234. Epub 2015 Apr 29.

Supplemental Content

Support Center